Skip to main content
SpringerLink
Log in

Increased Renal Clearance of Cefsulodin Due to Higher Glomerular Filtration Rate in Cystic Fibrosis

  • Original Research Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Summary

The steady-state renal clearance of cefsulodin was studied in 6 patients with cystic fibrosis and 8 healthy controls. The drug was administered by constant rate infusion to obtain 2 values of plasma concentration, 2 and 30 mg/L. As an estimate of the glomerular filtration rate, the renal clearance of inulin was measured simultaneously.

The results showed the figures for inulin clearance to be approximately 30% higher in cystic fibrosis patients than in healthy controls at both concentrations, and a corresponding increase in the renal clearance of cefsulodin was seen in patients over controls. The ratio between the renal clearances of the 2 substances was on average 0.9 in both groups.

The correlation found between the 2 renal clearances (r = 0.75; p < 0.001) indicates that glomerular filtration rate has considerable influence on the renal elimination of cefsulodin. This finding emphasises the importance of glomerular filtration rate for the renal clearance of drugs in cystic fibrosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aladjem M, Lotan D, Boichis H, Orda S, Katznelson D. Renal function in patients with cystic fibrosis. Nephron 34: 84–86, 1983

    Article  PubMed  CAS  Google Scholar 

  • Arvidsson A, Alván G, Strandvik B. Difference in renal handling of cefsulodin between patients with cystic fibrosis and normal subjects. Acta Paediatrica Scandinavica 72: 293–294, 1983

    Article  PubMed  CAS  Google Scholar 

  • Assael BM, Marra G, Tirelli AS, Cavanna G, Claris Appiani A, et al. Renal function in cystic fibrosis. International Journal of Pediatric Nephrology 7: 213–216, 1986

    PubMed  CAS  Google Scholar 

  • Berg U, Kusoffsky E, Strandvik B. Renal function in cystic fibrosis with special reference to the renal sodium handling. Acta Paediatrica Scandinavica 71: 833–838, 1982

    Article  PubMed  CAS  Google Scholar 

  • Blantz CR, Pelayo JC. A functional role for the tubulo-glomerular feedback mechanism. Kidney International 25: 739–746, 1984

    Article  PubMed  CAS  Google Scholar 

  • Carlstedt-Duke J, Bronnegard M, Strandvik B. Pathological regulation of arachidonic acid release in cystic fibrosis: the putative basic defect. Proceedings of the National Academy of Sciences 83: 9202–9206, 1986

    Article  CAS  Google Scholar 

  • de Groot R, Smith AL, Antibiotic pharmacokinetics in cystic fibrosis. Differences and clincial significance. Clinical Pharmacokinetics 13: 228–253, 1987

    Article  PubMed  Google Scholar 

  • Finkelstein E, Hall K. Aminoglycoside clearance in patients with cystic fibrosis. Journal of Pediatrics 94: 163–164, 1979

    PubMed  CAS  Google Scholar 

  • Gibson TP, Granneman GR, Kallal JE, Sennello LT. Cefsulodin kinetics in renal impairment. Clinical Pharmacology and Therapeutics 31: 602–608, 1982

    Article  PubMed  CAS  Google Scholar 

  • Granneman GR, Sennello LT. Precise high-performance liquid Chromatographic procedure for the determination of cefsulodin, a new antipseudomonal cephalosporin antibiotic, in plasma. Journal of Pharmaceutical Sciences 71: 1112–1115, 1982

    Article  PubMed  CAS  Google Scholar 

  • Granneman GR, Sennello LT, Sonders RC, Wynne B, Thomas EW. Cefsulodin kinetics in healthy subjects after intramuscular and intravenous injection. Clinical Pharmacology and Therapeutics 31: 95–103, 1982

    Article  PubMed  CAS  Google Scholar 

  • Hedman A, Adan-Abdi Y, Alván G, Strandvik B, Arvidsson A. Influence of the glomerular filtration rate on renal clearance of ceftazidime in cystic fibrosis. Clinical Pharmacokinetics 15: 57–65, 1988

    Article  PubMed  CAS  Google Scholar 

  • Hilger HH, Klumper JD, Ullrich KJ. Wasserruckresorption und Jonentransport durch die Sammelsrohrzellen der Saugetierniere. Pflugers Archiv — European Journal of Physiology 267: 218–237, 1958

    Article  PubMed  CAS  Google Scholar 

  • Jusko WJ, Mosovich LL, Gerbracht LM, Mattar ME, Yaffe SJ. Enhanced renal excretion of dicloxacillin in patients with cystic fibrosis. Pediatrics 56: 1038–1044, 1975

    PubMed  CAS  Google Scholar 

  • Leeder JS, Spino M, Isles AF, Tesoro AM, Gold R, et al. Ceftazidime disposition in acute and stable cystic fibrosis. Clinical Pharmacology and Therapuetics 36: 355–362, 1984

    Article  CAS  Google Scholar 

  • Matzke GR, Keane WF. Cefsulodin pharmacokinelics in patients with various degrees of renal function. Antimicrobial Agents and Chemotherapy 23: 369–373, 1983

    Article  PubMed  CAS  Google Scholar 

  • McPherson MA, Dormer RL. The molecular and biochemical basis of cystic fibrosis. Bioscience Reports 7: 167–185, 1987

    Article  PubMed  CAS  Google Scholar 

  • Reed MD, Stern RC, Yamashita TS, Ackers J, Myers CM, et al. Single-dose pharmacokinetics of cefsulodin in patients with cystic fibrosis. Antimicrobial Agents and Chemotherapy 25: 579–581, 1984

    Article  PubMed  CAS  Google Scholar 

  • Robson AM, Tateishi S, Ingelfinger JR, Strominger DB, Klahr S. Renal function in patients with cystic fibrosis. Journal of Pediatrics 79: 42–50, 1971

    Article  PubMed  CAS  Google Scholar 

  • Schachter SH. Spino M. Isles AF. Tesoro A, Prober C. et al. Pharmacokinetics of cefoperazone in patients with cystic fibrosis and healthy volunteers. Proceedings of the 13th International Congress of Chemotherapy. Vienna, August 28–September 2, 1983, pp. 45–48, 1983

  • Schoeller J. Fillastre J. Humbert G, Lecaillon JB. Pharmacokinetics of cefsulodin in patients with renal insufficiency. In Periti & Grassi (Eds) Current chemotherapy and immunotherapy, pp. 526–527, American Society for Microbiology, Washington, D.C. 1982

    Google Scholar 

  • Shwachman H, Kulczycki LL. Long-term study of one hundred five patients with cystic fibrosis: studies made over a five- to fourteen-year period. American Journal of Diseases of Children 96: 6–16, 1958

    CAS  Google Scholar 

  • Spino M, Chai RP, Isles AF, Balfe JW, Brown RG, et al. Assessment of glomerular filtration rate and effective renal plasma flow in cystic fibrosis. Journal of Pediatrics 107: 64–70, 1985

    Article  PubMed  CAS  Google Scholar 

  • Spino M, Chai RP, Isles AF, Thiessen JJ, Tesoro A, et al. Cloxacillin absorption and disposition in cystic fibrosis. Journal of Pediatrics 105: 829–835, 1984

    Article  PubMed  CAS  Google Scholar 

  • Strandvik B, Bronnegård M. Carlstedt-Duke J. Arachidonic acid release in CF. In Mastella & Quinton (Eds) Cellular and molecular basis of cystic fibrosis, pp. 445–450, San Francisco Press, California, 1988

    Google Scholar 

  • Strandvik B, Bronnegård M, Gilljam H, Carlstedt-Duke J. Relation between defective regulation of arachidonic acid release and symptoms in cystic fibrosis. Scandinavian Journal of Gastroenterology 23(Suppl. 143): 1–4, 1988

    Article  Google Scholar 

  • Strandvik B, Ellin A. Gilljam H. Kallner A. Wiman LG. Fatty acid metabolism in cystic fibrosis. In Warwick (Ed) 1000 years of cystic fibrosis. p. 304. University of Minnesota. 1981

  • Talamo RC. Rosenstein BJ, Berninger RW. Cystic fibrosis. In Stanbury et al. (Eds) The metabolic basis of inherited disease, pp. 1899–1917, McGraw Hill, New York. 1983

    Google Scholar 

  • Yaffe SJ, Gerbracht LM, Mosovich LL, Mattar ME, Danish M, et al. Pharmacokinetics of methicillin in patients with cystic fibrosis. Journal of Infectious Diseases 35: 828–831, 1977

    Article  Google Scholar 

  • Zak O, Konopka EA, Tosch W, Ahrens T, Zimmerman W, et al. Experimental evaluation of CGP 7174/E (SCE 129). a new injectable cephalosporin antibiotic active against pseudomonas aeruginosa. Drugs Under Experimental and Clinical Research 5: 45–59, 1979

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Clinical Pharmacology and Pediatrics, Karolinska Institutet, Huddinge University Hospital, Huddinge, Sweden

    Ann Hedman, Gunnar Alván, Birgitta Strandvik & Annie Arvidsson

Authors
  1. Ann Hedman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gunnar Alván
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Birgitta Strandvik
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Annie Arvidsson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hedman, A., Alván, G., Strandvik, B. et al. Increased Renal Clearance of Cefsulodin Due to Higher Glomerular Filtration Rate in Cystic Fibrosis. Clin Pharmacokinet 18, 168–175 (1990). https://doi.org/10.2165/00003088-199018020-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-199018020-00006

Keywords

Search

Navigation